BRCA1 Expression and Outcome in Patients With EGFR-Mutant NSCLC Treated With Gefitinib Alone or in Combination With Olaparib
Titel:
BRCA1 Expression and Outcome in Patients With EGFR-Mutant NSCLC Treated With Gefitinib Alone or in Combination With Olaparib
Auteur:
Karachaliou, Niki Arrieta, Oscar Giménez-Capitán, Ana Aldeguer, Erika Drozdowskyj, Ana Chaib, Imane Reguart, Noemí Garcia-Campelo, Rosario Chen, Jing-Hua Molina-Vila, Miguel Angel Rosell, Rafael